Marinus Pharmaceuticals

About:

Marinus Pharmaceuticals reformulates, develops, and commercializes drugs to treat neurological, psychiatric, and pain disorders.

Website: http://www.marinuspharma.com

Twitter/X: marinuspharma

Top Investors: Oaktree Capital Management, Bain Capital Life Sciences, Canaan Partners, Sofinnova Investments, Domain Associates

Description:

Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings. The company was founded in 2003 and is based in Branford, Connecticut.

Total Funding Amount:

$452M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Branford, Connecticut, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)marinuspharma.com

Founders:

Harry H. Penner

Number of Employees:

101-250

Last Funding Date:

2022-11-07

IPO Status:

Public

© 2025 bioDAO.ai